© 2020 MJH Life Sciences and OncLive. All rights reserved.
January 21, 2020
Alison J. Moskowitz, MD, discusses important updates in Hodgkin lymphoma.
March 30, 2018
Alison J. Moskowitz, MD, clinical director, Lymphoma Inpatient Unit, Memorial Sloan Kettering Cancer Center, discusses the data that led to the approval of brentuximab vedotin (Adcetris) in patients with cutaneous T-cell lymphoma (CTCL).